Active Awards Portfolio Dashboard

It takes a lot of effort to develop a promising stem cell research idea into an effective treatment that can help patients. CIRM funds a pipeline of projects spanning discovery, translation and clinical stage research. Check out our portfolio of active research awards in our interactive dashboard below. For a detailed list of CIRM-funded clinical trials, visit our Clinical Trials Dashboard.

Filter Awards

Disease Cell Type Therapeutic or Technology Institution Stage Project Objective Details
Muscle Injury Adult Stem Cell Other Components UCSF
Development Candidate, Proof of Concept
Skeletal/Smooth Muscle disorders Embryonic Stem Cell,
iPS Cell
Exosomes based therapy Stanford
Development Candidate, Proof of Concept
Sarcoma Adult Stem Cell Gene-modified, personalized cell therapy Stanford
Development Candidate, Proof of Concept
Type 1 diabetes Embryonic Stem Cell Gene-modified, donor cell therapy Salk
Development Candidate, Proof of Concept
Breast Cancer Adult Stem Cell Gene-modified, donor cell therapy Cytonus Therapeutics, Inc.
Development Candidate, Proof of Concept
Other Adult Stem Cell Protein/peptide therapy Intact Therapeutics, Inc.
Development Candidate, Proof of Concept
Immune Disease,
Severe Combined Immunodeficiency, Adenosine deaminase-deficient (ADA-SCID)
Adult Stem Cell Gene-modified, personalized cell therapy UCLA
Clinical Trial, Phase 2
IPEX Syndrome Adult Stem Cell Gene-modified, personalized cell therapy Stanford
Clinical Trial, Phase 1 or Phase 1/2
Wounds, ulcers Small molecule therapy UCLA
IND
Solid Tumors Adult Stem Cell Personalized cell therapy BioEclipse Therapeutics INC.
Clinical Trial, Phase 1 or Phase 1/2
Retinitis Pigmentosa Somatic Cell Gene Therapy, cell free Ray Therapeutics, INC
Pre-IND/IDE or Equivalent
Hypertension, pulmonary arterial Adult Stem Cell Gene-modified, personalized cell therapy UCLA
Pre-IND/IDE or Equivalent
Prostate Cancer Gene-modified, personalized cell therapy USC
Pre-IND/IDE or Equivalent
Kidney Failure Adult Stem Cell Device UC Davis
Pre-IND/IDE or Equivalent
Muscle Injury Adult Stem Cell Personalized cell therapy UC Davis
Clinical Trial, Phase 1 or Phase 1/2
Epilepsy Embryonic Stem Cell Donor cell therapy Neurona Therapeutics
Clinical Trial, Phase 1 or Phase 1/2
Heart failure Gene Therapy, cell free Tenaya Therapeutics, Inc.
Development Candidate
Blood Disorders Adult Stem Cell Antibody Stanford
Development Candidate
Alpha Thalassemia Major Adult Stem Cell Gene-modified, personalized cell therapy UCLA
Development Candidate
Blood Disorders Adult Stem Cell Gene-modified, personalized cell therapy UCLA
Development Candidate, Proof of Concept
Epilepsy,
Other
iPS Cell Gene Therapy, cell free UC Davis
Development Candidate, Proof of Concept
Blood Disorders Adult Stem Cell Small molecule therapy Scripps
Development Candidate, Proof of Concept
Intestinal Disease iPS Cell Exploring disease mechanisms Cedars-Sinai
Proof of Concept, Tool/Resources/Bottleneck
Pancreatic Cancer Cancer Stem Cell Antibody UCSD
Development Candidate
Leukemia Cancer Stem Cell Biologic UCLA
Development Candidate
Alzheimer's Disease,
Parkinson's Disease
iPS Cell Small molecule therapy Scripps
Development Candidate, Proof of Concept
Autism,
Epilepsy,
Other
iPS Cell Nucleic acid based therapy UCSD
Development Candidate, Proof of Concept
Vision Loss Embryonic Stem Cell,
iPS Cell
Gene Therapy, cell free UCLA
Development Candidate, Proof of Concept
iPS Cell Model system development Nanotools Bioscience
Proof of Concept
Type 1 diabetes Embryonic Stem Cell,
iPS Cell
Donor cell therapy Minutia, Inc.
Development Candidate, Proof of Concept
Ovarian Cancer Adult Stem Cell Gene-modified, donor cell therapy UCLA
Development Candidate
Solid Tumors Somatic Cell Gene-modified, personalized cell therapy UC Irvine
Development Candidate
HIV/AIDS Adult Stem Cell Gene-modified, personalized cell therapy Scintillon Inst
Development Candidate, Proof of Concept
Heart failure iPS Cell Nucleic acid based therapy Gladstone
Development Candidate, Proof of Concept
Autism iPS Cell Donor cell therapy UCSD
Development Candidate, Proof of Concept
Bladder or Urinary Tract Disorder Somatic Cell Tissue engineering Wake Forest University Health Sciences
Clinical Trial, Phase 1 or Phase 1/2
X-linked Chronic Granulomatous Disease Adult Stem Cell Gene-modified, personalized cell therapy ImmunoVec
Clinical Trial, Phase 1 or Phase 1/2
HIV/AIDS Gene Therapy, cell free Excision BioTherapeutics
Clinical Trial, Phase 1 or Phase 1/2
Breast Cancer,
Melanoma
Somatic Cell Donor cell therapy Calidi Biotherapeutics, Inc.
IND
Brain Cancer Adult Stem Cell Gene-modified, donor cell therapy COH
Clinical Trial, Phase 1 or Phase 1/2
Metabolic Disorders,
Neurological Disorders
Somatic Cell Stanford
IND
Anemia,
Bone Marrow Transplant and Viral Infection
Adult Stem Cell Immune tolerance/management Stanford
Clinical Trial, Phase 1 or Phase 1/2
Colon Cancer Tachyon Therapeutics, Inc
Clinical Trial, Phase 1 or Phase 1/2
Neurological Disorders,
Other
Adult Stem Cell Gene-modified, personalized cell therapy UCSD
Pre-IND/IDE or Equivalent
B cell cancers Gene-modified, personalized cell therapy UC Davis
Pre-IND/IDE or Equivalent
Neurological Disorders Gene Therapy, cell free Mahzi Therapeutics
Pre-IND/IDE or Equivalent
Breast Cancer Adult Stem Cell Gene-modified, donor cell therapy COH
Pre-IND/IDE or Equivalent
Other iPS Cell Model system development Greenstone Biosciences
Tool/Resources/Bottleneck
Leukemia, Acute Myeloid (AML) Cancer Stem Cell Gene-modified, personalized cell therapy UCSF
IND
Neurological Disorders Adult Stem Cell Gene-modified, personalized cell therapy UC Davis
IND

Pages

Icon for csv export